RRM2 and neoplasm: Further study found that the reduction in RRM2 gene expression was found to be directly correlated with a decrease in AKT phosphorylation levels, ultimately leading to a heightened anti-tumor effect of docetaxel (Figs. 5 B, C; 6A).